Massive study probes SGLT2 Drugs' impact on kidney anemia
NCT ID NCT07063316
First seen Mar 06, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study examines whether SGLT2 inhibitors, a type of diabetes medication, are linked to anemia in people with chronic kidney disease (CKD). Researchers will analyze health records from 15,000 patients in Japan to track anemia development, treatments, and costs. The goal is to better understand how these drugs influence anemia management, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co ., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.